Bone marrow stromal cell lines having high potential for osteoclast-supporting activity express PPARgamma1 and show high potential for differentiation into adipocytes
- PMID: 18095059
- DOI: 10.1007/s00774-007-0787-3
Bone marrow stromal cell lines having high potential for osteoclast-supporting activity express PPARgamma1 and show high potential for differentiation into adipocytes
Abstract
Bone marrow stromal cells support osteoclast differentiation by expressing receptor activator of NF-kB ligand (RANKL). Although several bone marrow stromal cell lines have been established and characterized, the differentiation stage of the supporting cells for osteoclast differentiation remains unclear. We have established several bone marrow stromal cell lines from transgenic mice harboring the temperature-sensitive SV40 large T antigen. Some of these temperature-sensitive bone marrow stromal cell lines (TSB cell lines) support osteoclast differentiation and differentiate into osteoblasts, suggesting that osteoblast precursor cells support osteoclast differentiation. Here we show that the TSB cell lines that support osteoclast differentiation also expressed peroxisome proliferator-activated receptor gamma1 (PPARgamma1) and were able to differentiate into adipocytes. PPARgamma1 is an alternatively spliced form of PPARgamma that is responsible for the adipocyte differentiation and expressed in the adipocyte precursor cells. Immunofluorescence analysis of TSB cell lines and primary bone marrow stromal cells by use of anti-PPARgamma and anti-RANKL antibodies showed that fluorescent signals for RANKL were observed in the cells that expressed PPARgamma. Furthermore, activation of adipocyte differentiation by a PPARgamma agonist led to decreased RANKL expression. These results demonstrate that PPARgamma1-positive precursor cells for osteoblasts and adipocytes expressed RANKL and supported osteoclastogenesis.
Similar articles
-
Relationship between the ability to support differentiation of osteoclast-like cells and adipogenesis in murine stromal cells derived from bone marrow.Prostaglandins Leukot Essent Fatty Acids. 2000 May;62(5):319-27. doi: 10.1054/plef.2000.0161. Prostaglandins Leukot Essent Fatty Acids. 2000. PMID: 10883064
-
Identification and characterization of mouse bone marrow stromal cell lines immortalized by temperature-sensitive SV40 T antigen: supportive activity for osteoclast differentiation.Bone. 2001 Sep;29(3):236-41. doi: 10.1016/s8756-3282(01)00505-1. Bone. 2001. PMID: 11557367
-
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0. Bone. 1999. PMID: 10574571
-
At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives.Int J Mol Sci. 2020 Mar 26;21(7):2277. doi: 10.3390/ijms21072277. Int J Mol Sci. 2020. PMID: 32224846 Free PMC article. Review.
-
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.Endocr Rev. 1999 Jun;20(3):345-57. doi: 10.1210/edrv.20.3.0367. Endocr Rev. 1999. PMID: 10368775 Review.
Cited by
-
Pathophysiology of the cochlear intrastrial fluid-blood barrier (review).Hear Res. 2016 Aug;338:52-63. doi: 10.1016/j.heares.2016.01.010. Epub 2016 Jan 20. Hear Res. 2016. PMID: 26802581 Free PMC article. Review.
-
Bone equilibria and disruptions.J Pediatr Soc North Am. 2024 Apr 6;7:100059. doi: 10.1016/j.jposna.2024.100059. eCollection 2024 May. J Pediatr Soc North Am. 2024. PMID: 40433272 Free PMC article.
-
Minireview: nuclear receptor regulation of osteoclast and bone remodeling.Mol Endocrinol. 2015 Feb;29(2):172-86. doi: 10.1210/me.2014-1316. Epub 2014 Dec 30. Mol Endocrinol. 2015. PMID: 25549044 Free PMC article. Review.
-
Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators.PLoS One. 2014 Oct 10;9(10):e108920. doi: 10.1371/journal.pone.0108920. eCollection 2014. PLoS One. 2014. PMID: 25302610 Free PMC article.
-
The effect of thiazolidinediones on bone mineral density in Chinese older patients with type 2 diabetes.J Bone Miner Metab. 2010;28(1):77-81. doi: 10.1007/s00774-009-0104-4. Epub 2009 Jul 16. J Bone Miner Metab. 2010. PMID: 19603247
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources